MediWound Ltd. is a biotechnology niche specialty company. 
Established in 2001, MediWound is committed to develop, manufacture & commercialize global "added value" innovative products to address unmet needs in the fields of burn and wound management.

 MediWound's innovative flagship product, Debrase® Gel Dressing (DGD), is an effective, selective, fast and safe burn wound debridement agent.

MediWound operates a manufacturing facility for sterile pharmaceutical products that meets high quality requirements.